Articles tagged "Kidney transplantation"

2018 American Transplant Congress
One-Year Outcomes in Patients with Advanced Liver Fibrosis or Compensated Cirrhosis from Chronic Hepatitis C Receiving Kidney Transplant Alone
P. Brown, F. Kumssa, D. Venkat.
Henry Ford Hospital, Detroit.
Background: Hepatitis C (HCV) was difficult to treat post-kidney transplant prior to the direct acting antiviral (DAA) era. As such patients with advanced fibrosis and…
2018 American Transplant Congress
Recipient Outcomes in Age Mismatched Living Kidney Transplants from Donors > 60 Years: A UNOS Database Analysis
O. Adebiyi, A. Riaz, M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin.
Indiana University, Indianapolis.
Background: Donor and recipient age mismatch kidney transplantation are known to affect graft survival. We examined the impact of age mismatching on graft survival after…
2018 American Transplant Congress
Prostate Cancer Characteristics in Men on Immunosuppressive Medications
M. Eltemamy, A. Elshafei, A. Salah, Y. Nyame, H. Arora, A. Wee, V. Krishnamurthi, S. Jones.
Cleveland Clinic, Cleveland.
INTRODUCTION: To assess the prevalence of prostate cancer (PCa) in men receiving immunosuppressive medications undergoing transrectal ultrasound guided (TRUS) prostate biopsy.METHODS: A total of 468…
2018 American Transplant Congress
Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants
S. Pineda,¹ T. Sigdel,¹ J. Chen,¹ A. Jackson,² M. Sirota,¹ M. Sarwal.¹
¹UCSF, San Francisco; ²Johns Hopkins University, Baltimore.
Transplant (tx) injury from antibody mediated (AMR) and T cell mediated (CMR) rejection, limits indefinite survival after HLA mismatched organ tx. AMR is incompletely diagnosed…
2018 American Transplant Congress
Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era
K. Lentine, D. Axelrod,² R. Bloom,³ H. Xiao,¹ D. Segev,⁴ T. Alhamad,⁵ H. Randall,¹ R. Ouseph,¹ V. Dharnidharka,⁵ D. Brennan,⁴ N. Lam,⁶ A. Naik,⁷ G. Hess,⁸ B. Kaiske,⁹ M. Schnitzler.¹
¹Saint Louis U, St. Louis; ²Lahey, Burlington; ³U Penn, Philadelphia; ⁴Johns Hopkins, Baltimore; ⁵Washington U, St. Louis; ⁶U Alberta, Edmonton, Canada; ⁷U Michigan, Ann Arbor; ⁸Hennepin, Minneapolis; ⁹Symphony Health, Conshohocken.
Hepatitis C virus (HCV) infection in kidney transplant (KTx) donors or recipients has correlated with adverse outcomes, partly due to limited treatment options. Development of…
2018 American Transplant Congress
IgA Recurrence in a Single Center with a Protocol Biopsy Program
M. Merzkani, N. Lepori, M. El Ters, F. Cosio, H. Amer.
Mayo Clinic, Rochester, MN.
The objective of this study was to determine the rate of recurrence of IgA nephropathy in our program aided by protocol biopsies and protocol driven…
2018 American Transplant Congress
Risk Factors for Chronic Opioid Use after Kidney Transplantation
J. Fleming, D. Taber, R. Gilbert, L. Wilson, Z. Elmaasarani, B. O'Brien, N. Patel, N. Pilch, S. Ball, P. Mauldin, P. Baliga.
MUSC, Charleston, SC.
Opioid use is associated with increased complications, graft loss, and mortality in the kidney transplant (KTX) population. The aim of our study was to identify…
2018 American Transplant Congress
Development and Validation of a Socioeconomic Kidney Transplant Derailers Index (KTDI)
J. Peipert,^1,2 J. Beaumont,² M. Robbins,³ A. Paiva,³ C. Anderson,¹ A. Waterman.^1,2
¹UCLA, Los Angeles, CA; ²Terasaki Research Institute, Los Angeles, CA; ³Univ. of Rhode Island, Kingston, RI.
Transplant evaluation requires an assessment of socioeconomic challenges patients face that may derail them from obtaining a kidney transplant (KT). We developed and validated a…
2018 American Transplant Congress
QPI-1002, a siRNA Targeting p53: Improvement in Outcomes Following Acute Kidney Injury (AKI): Cardiac Surgery to AKI Donors
J. Tchervenkov,² E. Squiers,¹ R. Stratta,³ D. Odenheimer,² D. Rothenstein,² QPI-1002 DGF Study Group.
¹Quark Pharmaceuticals, Fremont; ²McGill University Health, Montreal, Canada; ³Wake Forest School of Medicine Centre, Winston-Salem.
Background: QPI-1002 has been observed to statistically reduce the incidence, severity and duration of AKI in a large Phase 2 study of AKI following cardiac…
2018 American Transplant Congress
Association of Health Literacy with Adverse Outcomes among Kidney Transplant Candidates and Recipients
F. Warsame, C. Haugen, J. Garonzik-Wang, N. Desai, D. Crews, T. Purnell, M. McAdams-DeMarco, D. Segev.
Johns Hopkins University, Baltimore, MD.
Limited health literacy (LHL) is known to adversely affect health outcomes in patients managing chronic illness. We aimed to examine the association between LHL, listing,…